Pegylated liposomal doxorubicin
-
Extracorporeal Elimination of Circulating Pegylated Liposomal Doxorubicin (PLD) to Enhance the Benefit of Cytostatic Therapy in Platinum-Resistant Ovarian Cancer Patients
Ondřej Kubeček, Milan Bláha, Daniel Diaz-Garcia, Stanislav Filip
2015, Vol. 58, Issue 1, pp. 3-8
